Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > PGEN Precigen > Detailed Quotes

PGEN Precigen

2.080
-0.100-4.59%
Close 09/26 16:00 ET
High
2.220
Open
2.130
Turnover
2.31M
Low
2.040
Pre Close
2.180
Volume
1.10M
Market Cap
432.95M
P/E(TTM)
Loss
52wk High
5.600
Shares
208.15M
P/E(Static)
Loss
52wk Low
1.120
Float Cap
167.75M
Bid/Ask %
0.00%
Historical High
11.100
Shs Float
80.65M
Volume Ratio
0.97
Historical Low
1.120
Dividend TTM
--
Div Yield TTM
--
P/B
7.79
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.36%
Amplitude
8.26%
Avg Price
2.102
Lot Size
1
Float Cap
167.75M
Bid/Ask %
0.00%
Historical High
11.100
Shs Float
80.65M
Volume Ratio
0.97
Historical Low
1.120
Dividend TTM
--
P/B
7.79
Dividend LFY
--
Turnover Ratio
1.36%
Amplitude
8.26%
Avg Price
2.102
Lot Size
1
Price Forecast

No Data

News

Comment

No More
Company Overview More
Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the following segments: Biopharmaceuticals, Exemplar, and Trans Ova. The Biopharmaceuticals segment is involved in advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. It also engages in pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics. The Exemplar segment is focused on developing research models and services for healthcare research applications. The Trans Ova segment provides bovine reproductive technologies. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.
CEO: Dr. Helen Sabzevari, PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...